Publications
SELECTED PUBLICATIONS:
1) Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. AM HEART J 1999;137:79-92.
2) Kizer JR, Kimmel SE. The calcium-channel blocker controversy: historical perspective and lessons for future pharmacotherapies. An International Society of Pharmacoepidemiology 'hot topic.' PHARMACOEPIDEMIOL DRUG SAF 2000;9:25-36.
3) Kizer JR, Koniaris LS, Edelman JD, St John Sutton MG. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. CHEST 2000;118:1221-1223.
4) Kizer JR, Gefter WB, deLemos AS, Scoll BJ, Wolfe ML, Mohler ER. Electron beam computed tomography for the quantification of aortic valve calcification. J HEART VALVE DIS 2001;10:361-366.
5) Kizer JR, Kimmel SE. Epidemiologic review of the calcium-channel-blocker drugs: an up-to-date perspective on the proposed hazards. ARCH INTERN MED 2001;161:1145-1158.
6) Kizer JR, Silvestry FE, Kimmel SE, Kasner SE, Wiegers SE, Erwin MB, Schwalm SA, Viswanathan MN, Pollard JR, Keane MG, St John Sutton MG. Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography. AM J CARDIOL 2002;90:395-400.
7) Kizer JR, Berlin JA, Laskey WK, Schwartz JS, Sauer WH, Krone RJ, Kimmel SE. Limitations of current risk-adjustment models in the era of coronary stenting. AM HEART J 2003:145:683-692.
8) Kizer JR, Muttreja MR, Matthai WH, Mcconnell J, Nardonne H, Sonel AF, Keane MG, Wilensky RL. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. EUR HEART J 2003;24:1314-1322.
9) Kizer JR. Losartan in the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy: A Viewpoint. AM J CARDIOVASC DRUGS 2003;3:378-379.
10) Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel Se, Strieter RM, Arcasoy SM, Ferrari VA, Hansen-Flaschen J. Association between pulmonary fibrosis and coronary artery disease. ARCH INTERN MED 2004;164:551-556.
11) Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE. Practice parameter: risk of recurrent stroke and secondary stroke prevention in patients with patent foramen ovale and atrial septal aneurysm (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. NEUROLOGY 2004;62:1042-1050.
12) Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in Left Ventricular Strucuture Between Black and White Hypertensive Adults. The Hypertension Genetic Epidemiology Network Study. HYPERTENSION 2004;43:1182-1188.
13) Kizer JR, Dahlof B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB. Stroke Reduction in Hypertensive Adults with Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction In Hypertension Study. HYPERTENSION 2005;45:46-52.
14) Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, Best L, Resnick HE, Roman MJ, Devereux RB. Mitral Annular Calcification, Aortic-Valve Sclerosis and Incident Stroke in Adults Free of Clinical Cardiovascular Disease: The Strong Heart Study. STROKE 2005;36:2533-2537.
15) Kizer JR, Devereux RB. Patent Foramen Ovale in Young Adults with Unexplained Stroke. N ENGL J MED 2005;353:2361-2372.
16) Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, Roman MJ, Devereux RB. Left Atrial Diameter as an Independent Predictor of First Clinical Cardiovascular Events in Middle-Aged and Elderly Adults: The Strong Heart Study. AM HEART J 2006;151:412-418.
17) Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of Transesophageal Echocardiography for Non-Bacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients with Cerebral Ischemia. AM J CARDIOL 2006;97:484-488.
18) Kizer JR, Devereux RB. Regression of Left Ventricular Hypertrophy: Lodestar to Stroke Prevention in the Treatment of Hypertension? AM J HYPERTENS 2006;19:439-442.
19) Karas MG, Francescone S, Segal AZ, Devereux RB, Roman MJ, Liu JE, Hahn RT, Kizer JR. Relation between Mitral Annular Calcium and Complex Aortic Atheroma in Patients with Cerebral Ischemia Referred for Transesophageal Echocardiography. AM J CARDIOL 2007;99:1306-1311.
20) Doufekias E, Segal AZ, Kizer JR. Cardiogenic and Aortogenic Brain Embolism. J AM COLL CARDIOL 2008;51:1049-1059.
21) Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and Risk of Coronary Heart Disease in Older Men and Women. J CLIN ENDOCRINOL METAB 2008;93:3357-3364.
22) Kizer JR. Evaluation of the Patient with Unexplained Stroke. CORON ARTERY DIS 2008;19:535-540.
23) Kizer JR, Krauser DG, Rodeheffer RJ, Burnett JC, Okin PM, Roman MJ, Umans JG, Best LG, Lee ET, Devereux RB. Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (From the Strong Heart Study). AM J CARDIOL 2009;104:247-253.
